Eustace Mullins

Total Page:16

File Type:pdf, Size:1020Kb

Eustace Mullins MURDER BY INJECTION The Story of the Medical Conspiracy Against America By EUSTACE MULLINS The National Council for Medical Research P.O. Box 1105 Staunton, Virginia 24401 1 MURDER BY INJECTION The Story of the Medical Conspiracy Against America First Edition Library of Congress Card Catalog No. 88-060694 Copyright © 1988 Eustace Mullins ALL RIGHTS RESERVED No part of this publication may be reproduced, stored in a retrieval system, or transmitted in any form or by any means—electronic, mechanical, photocopy, recording, or otherwise—without express prior permission, with the exception of brief excerpts in magazine articles and/or reviews. Printed in the United States of America 2 For BLAIR in appreciation of your unequalled dedication to American ideals 3 Contents 1. The Medical Monopoly 1 2. Quacks on Quackery 13 3. The Profits of Cancer 59 4. Death and Vaccination 129 5. The Fluoridation Conspiracy .148 6. Whither AIDS 169 7. The Action of Fertilizers 187 8. Contamination of the Food Supply 204 9. The Drug Trust 226 10. The Rockefeller Syndicate 310 4 Foreword The present work, the result of some forty years of investigative research, is a logical progression from my previous books: the expose of the international control of monetary issue and banking practices in the United States; a later work revealing the secret network of organizations through which these alien forces wield political power—the secret committees, foundations, and political parties through which their hidden plans are implemented; and now; to the most vital issue of all, the manner in which these depredations affect the daily lives and health of American citizens. Despite the great power of the hidden rulers, I found that only one group has the power to issue life or death sentences to any American—our nation's physicians. I discovered that these physicians, despite their great power, were themselves subjected to very strict controls over every aspect of their professional lives. These controls, surprisingly enough, were not wielded by any state or federal agency, although almost every other aspect of American life is now under the absolute control of the bureaucracy. The physicians have their own autocracy, a private trade association, the American Medical Association. This group, which is headquartered in Chicago, Illinois, had gradually built up its power until it assumed total control over medical schools and the accreditation of physicians. The trail of these manipulators led me straight to the same lairs of the international conspirators whom I had exposed in previous books. I knew that they had already looted America, reduced its military power to a dangerously low level, and imposed bureaucratic controls on every American. I now discovered that their conspiracies also directly affected the health of every American. This conspiracy has resulted in a documented decline in the health of our citizens. We now rank far down the list of civilized nations in infant mortality and other significant medical statistics. I was able to document the shocking record of these cold-blooded tycoons who not only plan and carry out famines, economic depressions, revolutions and wars, but who also find their greatest profits in their manipulations of our medical care. The cynicism and malice of these conspirators is something beyond the imagination of most Americans. They deliberately mulct our people of millions of dollars each year through "charitable" organizations and then use these same organizations as key groups to bolster their Medical Monopoly. Fear and intimidation are the basic techniques by which the conspirators maintain their control over all aspects of our health care, as they ruthlessly crush any competitor who challenges their profits. As in other aspects of their "behavioural control" over the American people, their most constantly used weapon against us is their employment of federal agents and federal agencies to carry out 5 their intrigues. The proof of this operation may be the most disturbing revelation of my work. Eustace Mullins February 22, 1988 6 Acknowledgement: I am grateful to the staff of the Library of Congress in Washington, D.C. for their courtesy and cooperation in the preparation of this work. 7 Chapter 1 The Medical Monopoly The practice of medicine may not be the world's oldest profession, but it is often seen to be operating on much the same principles. Not only does the client wonder if he is getting what he is paying for, but in many instances, he is dismayed to find that he has actually gotten something he had not bargained for. An examination of the record shows that the actual methods of medical practice have not changed that much through the eons. The recently discovered Ebers papyrus shows that as early as 1600 B.C., more than nine hundred prescriptions were available to the physician, including opium as a pain-killing drug. As late as 1700, commonly used medications included cathartics such as senna, aloe, figs and castor oil. Intestinal worms were treated by aspidium roots (the male fern), pomegranate bark, or wormseed oil. In the East this was obtained from the flowers of santonin; in the Western Hemisphere it was pressed from the fruit and leaves of chenopodium. Analgesics or pain relievers were alcohol, hyoscyamus leaves, and opium. Hyoscyamus contains scopolamine, used to induce "twilight sleep'' in modern medicine. In the sixteenth century, Arabs used colchicum, a saffron derivative, for rheumatic pains and gout. Cinchona bark, the source of quinine, was used to treat malaria; chaulmoogra oil was used for leprosy, and ipecac for amoebic dysentery. Burned sponge at one time was used as a treatment for goiter; its content of iodine provided the cure. Midwives used ergot to contract the uterus. Some two hundred years ago, the era of modern medicine was ushered in by Sir Humphry Davy's discovery of the anaesthetic properties of nitrous oxide. Michael Faraday discovered ether, and Wilhelm Surtner isolated morphine from opium. Until the late nineteenth century, doctors practiced as free lance agents, which meant that they assumed all the risks of their decisions. The poor rarely encountered a doctor, as medical ministrations were generally confined to the rich and powerful. Curing a monarch could bring great rewards but failing to cure him could be a fatal mistake. Perhaps it was the awareness of the personal risks of this profession which gave rise to the plan for monopoly, to level out the risks and rewards among a chosen few. The attempts to build up this medical monopoly have now created a modern plague, while the resolve to maintain this monopoly has cost the public dearly in money and suffering. 8 Almost five centuries ago, one of the first attempts to set up this monopoly took place in England. The Act of 1511, signed into law by King Henry the Eighth, in England, made it an offence to practice physic or surgery without the approval of a panel of "experts." This Act was formalized in 1518 with the founding of the Royal College of Physicians. In 1540, barbers and surgeons were granted similar powers, when the King granted approval of their company. They immediately launched a campaign to eliminate the unauthorized practitioners who had served the poor. Apparently there is nothing new under the sun, as much the same campaign has long been underway in the United States. This harassment of doctors who served the poor caused such widespread suffering in England that King Henry the 8th was forced to enact the Quacks Charter in 1542. This Charter exempted the "unauthorized practitioners" and allowed them to continue their ministrations. No such charter has ever been granted in the United States, where a "quack" is not only an unauthorized practitioner, that is, one who has not been "approved" by the American Medical Association or one of the government agencies under its control, but he is also subject to immediate arrest. It is interesting that the chartering of quacks is not one of the features of English life which was passed on to its American colony. In 1617, the Society of Apothecaries was formed in England. In 1832, the British Medical Association was chartered; this became the impetus for the forming of a similar association, the American Medical Association, in the United States. From its earliest inception, the American Medical Association has had one principal objective, attaining and defending a total monopoly of the practice of medicine in the United States. From its outset, the AMA made allopathy the basis of its practice. Allopathy was a type of medicine whose practitioners had received training in a recognized academic school of medicine, and who relied heavily on surgical procedures and the use of medications. The leaders of this brand of medicine had been trained in Germany. They were dedicated to the frequent use of bleeding and heavy doses of drugs. They were inimical to any form of medicine which had not proceeded from the academies and which did not follow standardized or orthodox procedures. Allopathy set up an intense rivalry with the prevalent nineteenth school of medicine, the practice of homeopathy. This school was the creation of a doctor named Christian Hahnemann (1755-1843). It was based on his formula, "similibus cyrentur," like cures like. Homeopathy is of even greater significance to our time, because it works through the immune system, using nontoxic doses of substances which are similar to those causing the illness. Even today, Queen Elizabeth is still treated by her personal homeopathic physician at Buckingham Palace. Yet, in the United States, organized medicine continues its frenetic drive to discredit and stamp out the practice of homeopathic medicine. Ironically, Dr. George H. Simmons, who dominated the American Medical Association from 1899 to 1924, building that organization into a 9 national power, had for years run advertisements in Lincoln, Nebraska, where he practiced, which proclaimed that he was a "homeopathic physician." Clinical trials have shown that homeopathy is as effective as certain widely prescribed arthritic drugs, and also having the overriding advantage that it produces no harmful side effects.
Recommended publications
  • Nuremberg Revisited in Burma? an Assessment of the Potential Liability of Transnational Corporations and Their Officials in Burma Under International Criminal Law
    NUREMBERG REVISITED IN BURMA? AN ASSESSMENT OF THE POTENTIAL LIABILITY OF TRANSNATIONAL CORPORATIONS AND THEIR OFFICIALS IN BURMA UNDER INTERNATIONAL CRIMINAL LAW By Mary Ann Johnson Navis A dissertation submitted to the Victoria University of Wellington in partial fulfilment of the requirements for the degree of Master of Laws Victoria University of Wellington 2010 1 ABSTRACT This dissertation focuses on the role played by officials of transnational corporations and transnational corporations themselves in the situation in Burma. The main aim of this dissertation is to assess the liability of officials of transnational corporations in Burma and transnational corporations in Burma for crimes against humanity such as slave labour and for war crimes such as plunder under International Criminal Law. However at present transnational corporations cannot be prosecuted under International Criminal Law as the International Criminal Court only has jurisdiction to try natural persons and not legal persons. In doing this analysis the theory of complicity, actus reus of aiding and abetting and the mens rea of aiding and abetting in relation to officials of transnational corporations will be explored and analysed to assess the liability of these officials in Burma. In doing this analysis the jurisprudence of inter alia the Nuremberg cases, the cases decided by the International Criminal Tribunal for the Former Yugoslavia (ICTY) and the International Criminal Tribunal for Rwanda (ICTR) will be used. This dissertation also examines the problems associated with suing or prosecuting transnational corporations due to the legal personality of transnational corporations and the structure of transnational corporations. At the end of the dissertation some recommendations are made so as to enable transnational corporations to be more transparent and accountable under the law.
    [Show full text]
  • Beecham Group PLC and Another V Triomed (Pty) Ltd [2002] 4 All SA 193 (SCA)
    Beecham Group PLC and another v Triomed (Pty) Ltd [2002] 4 All SA 193 (SCA) Division: Supreme Court of Appeal Date: 19 September 2002 Case No: 100/01 Before: Harms, Scott, Mpati, Conradie JJA and Jones AJA Sourced by: PR Cronje Summarised by: D.Harris Parallel Citation: 2003 (3) SA 639 (SCA) . Editor's Summary . Cases Referred to . Judgment . [1] Intellectual property ­ Trade marks ­ Registration of shape as trade mark ­ Where shape is not intended to be used to distinguish owner's products from those of another, it cannot be regarded as a trade mark ­ Application for expungement from trade marks register therefore allowed. Editor's Summary Both parties involved in the present matter were players in the pharmaceutical industry. The Appellants sought the upholding of a trade mark for the shape of a tablet, and a finding that the Respondent had infringed the trade mark. The Respondent imported a tablet with the same composition and shape as that of the Appellants. In the court a quo, the Respondent applied for the expungement from the trade mark register of the shape trade mark. The Appellants launched a counter­application for relief for trade mark infringement. The latter application failed while that of the Respondent succeeded. Held ­ Interested parties may apply to court for the removal of an entry wrongly made or remaining on the trade mark register. The first question posed by the Court was whether the Appellants' shape mark constituted a trade mark in terms of section 10(1) of the Trade Marks Act 194 of 1993 ("the Act").
    [Show full text]
  • Karl Heinz Roth Die Geschichte Der IG Farbenindustrie AG Von Der Gründung Bis Zum Ende
    www.wollheim-memorial.de Karl Heinz Roth Die Geschichte der I.G. Farbenindustrie AG von der Gründung bis zum Ende der Weimarer Republik Einleitung . 1 Vom „Dreibund“ und „Dreierverband“ zur Interessengemeinschaft: Entwicklungslinien bis zum Ende des Ersten Weltkriegs . 1 Der Weg zurück zum Weltkonzern: Die Interessengemeinschaft in der Weimarer Republik . 9 Kehrtwende in der Weltwirtschaftskrise (1929/30–1932/33) . 16 Norbert Wollheim Memorial J.W. Goethe-Universität / Fritz Bauer Institut Frankfurt am Main 2009 www.wollheim-memorial.de Karl Heinz Roth: I.G. Farben bis zum Ende der Weimarer Republik, S. 1 Einleitung Zusammen mit seinen Vorläufern hat der I.G. Farben-Konzern die Geschichte der ersten Hälfte des 20. Jahrhunderts in exponierter Stellung mitgeprägt. Er be- herrschte die Chemieindustrie Mitteleuropas und kontrollierte große Teile des Weltmarkts für Farben, Arzneimittel und Zwischenprodukte. Mit seinen technolo- gischen Innovationen gehörte er zu den Begründern des Chemiezeitalters, das die gesamte Wirtschaftsstruktur veränderte. Auch die wirtschaftspolitischen Rahmenbedingungen gerieten zunehmend unter den Einfluss seiner leitenden Manager. Im Ersten Weltkrieg wurden sie zu Mitgestaltern einer aggressiven „Staatskonjunktur“, hinter der sich die Abgründe des Chemiewaffeneinsatzes, der Kriegsausweitung durch synthetische Sprengstoffe, der Ausnutzung der Annexi- onspolitik und der Ausbeutung von Zwangsarbeitern auftaten. Nach dem Kriegs- ende behinderten die dabei entstandenen Überkapazitäten die Rückkehr zur Frie- denswirtschaft
    [Show full text]
  • Explaining Corporate Success Abstract
    Explaining corporate success: Britain’s best performing firms, 1949-1985 D.M. Higgins, S. Toms The York Management School Abstract The paper synthesises theories of competitive advantage in a dynamic framework to explain the determinants of corporate success. A model is presented linking the firm’s resource audit and dynamic capabilities with the rate of market growth. For the purposes of testing the model, an examination of the performance of all British quoted companies during the period is conducted with reference to achieved long run average rates of return on capital employed. The best performing firms are analysed in more detail and their strategies mapped according to the model criteria. Conclusions are then drawn on the possible strategies for achieving long run corporate success in terms of above average financial returns. Correspondence Steven Toms Joint Editor: Business History Professor of Accounting and Finance and Head of School The York Management School Sally Baldwin Buildings University of York York YO10 5DD Tel: (44) 1904-434122 Fax: (44) 1904-433 431 Email: [email protected] http://www.york.ac.uk/management/staff/StaffProfiles/SToms.htm 1 Explaining corporate success: Britain’s best performing firms, 1949-1985 1. Introduction Competitive advantage and more specifically sustained competitive advantage and its determinants, has become an important research topic in the business and management and industrial organisation literatures. Sustained competitive advantage (SCA) implies not just achieving superior returns, but achieving them over a protracted period of time. It is therefore surprising that the overwhelming majority of this literature has not explored the notion of sustained competitive advantage from a historical perspective.
    [Show full text]
  • Glaxosmithkline Plc Annual Report for the Year Ended 31St December 2000
    GlaxoSmithKline 01 GlaxoSmithKline plc Annual Report for the year ended 31st December 2000 Contents Report of the Directors 02 Financial summary 03 Joint statement by the Chairman and the Chief Executive Officer 05 Description of business 29 Corporate governance 37 Remuneration report 47 Operating and financial review and prospects 69 Financial statements 70 Directors’ statements of responsibility 71 Report by the auditors 72 Consolidated statement of profit and loss 72 Consolidated statement of total recognised gains and losses 74 Consolidated statement of cash flow 76 Consolidated balance sheet 76 Reconciliation of movements in equity shareholders’ funds 77 Company balance sheet 78 Notes to the financial statements 136 Group companies 142 Principal financial statements in US$ 144 Financial record 153 Investor information 154 Shareholder return 156 Taxation information for shareholders 157 Shareholder information 158 Share capital 160 Cross reference to Form 20-F 162 Glossary of terms The Annual Report was approved by the Board 163 Index of Directors on 22nd March 2001 and published on 12th April 2001. Contact details 02 GlaxoSmithKline Financial summary 2000 1999 Increase Business performance £m £m CER % £ % Sales 18,079 16,164 9 12 Trading profit 5,026 4,378 12 15 Profit before taxation 5,327 4,708 11 13 Earnings/Net income 3,697 3,222 13 15 Earnings per Ordinary Share 61.0p 52.7p 14 16 Total results Profit before taxation 6,029 4,236 Earnings/Net income 4,154 2,859 Earnings per Ordinary Share 68.5p 46.7p Business performance: results exclude merger items and restructuring costs; 1999 sales and trading profit exclude the Healthcare Services businesses which were disposed of in 1999.
    [Show full text]
  • JANUARY 2017 | VOLUME 102 NUMBER 1 | AMERICAN COLLEGE of SURGEONS Bulletin Contents
    JANUARY 2017 | VOLUME 102 NUMBER 1 | AMERICAN COLLEGE OF SURGEONS Bulletin Contents FEATURES COVER STORY: Reimbursement changes in 2017 The 2017 Medicare physician fee schedule: An overview of provisions that will affect surgical practice 11 Lauren Foe, MPH; Jan Nagle, MS, RPh; and Vinita Ollapally, JD 2017 CPT coding changes 16 Albert Bothe, MD, FACS; Megan McNally, MD, FACS; and Jan Nagle, MS, RPh Profiles in surgical research: Mary T. Hawn, MD, MPH, FACS 26 Juliet A. Emamaullee, MD, PhD, FRCSC, and Kamal M. F. Itani, MD, FACS The 2016 RAS-ACS annual Communications Committee essay contest: An introduction 33 Erin Garvey, MD | 1 First-place essay: Paying it forward: When the mentee becomes the mentor 34 Kevin Koo, MD, MPH, MPhil Highlights of Clinical Congress 2016 35 ACS Officers, Regents, and Board of Governors’ Executive Committee 46 JAN 2017 BULLETIN American College of Surgeons Contents continued COLUMNS A look at The Joint Commission: ASCPA-SurgeonsPAC makes an Annual report provides details impact on 2016 congressional Looking forward 8 on patient safety, quality elections 80 David B. Hoyt, MD, FACS improvements 69 Katie Oehmen ACS NSQIP Best Practices case Carlos A. Pellegrini, MD, Call for nominations for the ACS studies: Impact of SSI reduction FACS, FRCSI(Hon), FRCS(Hon), Board of Regents and ACS strategy after colorectal resection 49 FRCSEd(Hon) Officers-Elect 82 Lisa A. Wilbert, RN NTDB data points: Annual Report Nominations for 2017 Dispatches from rural surgeons: 2016: Almost a 10 71 volunteerism and humanitarian Rural surgery: High pressure Richard J. Fantus, MD, FACS awards due February 28 84 but rewarding 55 Report on ACSPA/ACS activities, Susan Long, MD, FACS NEWS October 2016 86 From residency to retirement: In memoriam: Jay L.
    [Show full text]
  • I.G. Farben's Petro-Chemical Plant and Concentration Camp at Auschwitz Robert Simon Yavner Old Dominion University
    Old Dominion University ODU Digital Commons History Theses & Dissertations History Summer 1984 I.G. Farben's Petro-Chemical Plant and Concentration Camp at Auschwitz Robert Simon Yavner Old Dominion University Follow this and additional works at: https://digitalcommons.odu.edu/history_etds Part of the Economic History Commons, and the European History Commons Recommended Citation Yavner, Robert S.. "I.G. Farben's Petro-Chemical Plant and Concentration Camp at Auschwitz" (1984). Master of Arts (MA), thesis, History, Old Dominion University, DOI: 10.25777/7cqx-5d23 https://digitalcommons.odu.edu/history_etds/27 This Thesis is brought to you for free and open access by the History at ODU Digital Commons. It has been accepted for inclusion in History Theses & Dissertations by an authorized administrator of ODU Digital Commons. For more information, please contact [email protected]. 1.6. FARBEN'S PETRO-CHEMICAL PLANT AND CONCENTRATION CAMP AT AUSCHWITZ by Robert Simon Yavner B.A. May 1976, Gardner-Webb College A Thesis Submitted to the Faculty of Old Dominion University in Partial Fulfillment of the Requirements for the Degree of MASTER OF ARTS HISTORY OLD DOMINION UNIVERSITY August 1984 Approved by: )arw±n Bostick (Director) Reproduced with permission of the copyright owner. Further reproduction prohibited without permission. Copyright by Robert Simon Yavner 1984 All Rights Reserved Reproduced with permission of the copyright owner. Further reproduction prohibited without permission. ABSTRACT I.G. FARBEN’S PETRO-CHEMICAL PLANT AND CONCENTRATION CAMP AT AUSCHWITZ Robert Simon Yavner Old Dominion University, 1984 Director: Dr. Darwin Bostick This study examines the history of the petro­ chemical plant and concentration camp run by I.G.
    [Show full text]
  • Upper West Side / Central Park
    Upper West Side / Central Park Streets West 87 Street, K4-8 West 107 Street, A3-8 Beresford Apartments, The, M8 Summit Rock, M9 Contemporary African Art Gallery, A3 Greystone Hotel, H5 JHS 54, A7 Nicholas Roerich Museum, A3 Riverside Montessori School, G3 St. Ignatius Episcopal Church, K4 Symphony Space, G4 Subway Stations Amsterdam Avenue, A-M5 West 88 Street, J4-8 West 108 Street, A3-8 Bloomingdale Playground, B6 Tennis Courts, F10 Days Hotel, G5 Grosvenor Neighborhood House Kateri Residence, K2 Normandy Apartments, K2 Riverside Park, A2-M2 St. Mary Magdalen Orth. Church, A7 Thalia Theater, F4 81 St-Musuem of Natural History Key Broadway, A4, E-M5 West 89 Street, J4-8 West Drive, B10, F9, M9 Bloomingdale Public Library, D6 The Loch, C11 De La Salle Academy, F5 YMCA, B6 La Perla Community Garden, B7 Open Door Child Care Center, D7 Beach Volleyball Courts, B2 St. Matthew & St. Timothy Trinity Lutheran Church, D6 BC, M9 accessible Central Park West, A-M8 West 90 Street (Henry J. West End Avenue, A-M4 Brandon Residence for Women, L3 The Pool, C9 Douglass Houses, C6, C7 Harcourt Residence Hotel, F4 Louis Brandeis High School, L6 Park West Montessori School, C8 Crabapple Grove Garden, G2 Episcopal Church, L7 Trinity School, H6 86 St 1, K5 entrance & exit Columbus Avenue, A-M7 Browne Blvd), J4-8 Bretton Hall, L5 Central Park Hostel, C8 Dwight School, J8 Head Start, A6, C4, C7, F7, H7, K6 Malibu Studios Hotel, C5 Park West Village, E6, E7 Dinosaur Playground, E2 St. Matthew’s & St. Timothy’s Ukrainian Orthodox Church, M6 86 St , K9 Subway station and BC exits Duke Ellington Blvd West 91 Street, H4-8 Points of Interest Brewster Hotel, K8 Chabad Lubavitch of the West Side, G6 Edward A.
    [Show full text]
  • Government Gazette Republic of Namibia
    GOVERNMENT GAZETTE OF THE REPUBLIC OF NAMIBIA N$16.68 WINDHOEK- 2 September 1996 No. 1396 CONTENTS TRADE MARKS .............................................................................................................................. APPLICATIONS FOR REGISTRATION OF TRADE MARKS IN NAMIBIA (Applications accepted in terms of Act No. 48 of 1973) '\ Any person who has grounds for objection to any of the following trade marks, may, within the prescribed time, lodge Notice of Opposition on form SM6 con­ tained in the Second Schedule to the Trade Marks Rules in Namibia, 1973. The prescribed time is two months after the date of advertisement. This period may on application be extended by the Registrar. Where the Gazette is issued late, the period of opposition will count as from the date of issue and a notice relating thereto will be displayed on the public notice board in the Trade Marks Registry. Formal opposition should not be lodged until after notice has been given by letter to the applicant for registration so as to afford him an opportunity of withdrawing his application before the expense of preparing the Notice of Opposition is in­ curred. Failing such notice to the applicant an opponent may not succeed in ob­ taining an order for costs. "B" preceding the number indicates Part B of the Trade Mark Register. Neither the office mentioned hereunder nor Central Bureau Services (Pty) Ltd., acting on behalf of the Government of Namibia, guarantee the accuracy of this publication or undertake any responsibility for errors or omissions or their conse­ quences. E.T. KAMBOUA REGISTRAR OF TRADE MARKS FOR NAMIBIA 2 Government Gazette 2 September 1996 No. 1396 TRADE MARKS REMOVED FROM 1 JULY 1992 TO 30 JUNE 1996 NO.
    [Show full text]
  • A Thesis Entitled an Oral Dosage Form of Ceftriaxone Sodium Using Enteric
    A Thesis entitled An oral dosage form of ceftriaxone sodium using enteric coated sustained release calcium alginate beads by Darshan Lalwani Submitted to the Graduate Faculty as partial fulfillment of the requirements for the Master of Science Degree in Pharmaceutical Sciences with Industrial Pharmacy Option _________________________________________ Jerry Nesamony, Ph.D., Committee Chair _________________________________________ Sai Hanuman Sagar Boddu, Ph.D, Committee Member _________________________________________ Youssef Sari, Ph.D., Committee Member _________________________________________ Patricia R. Komuniecki, PhD, Dean College of Graduate Studies The University of Toledo May 2015 Copyright 2015, Darshan Narendra Lalwani This document is copyrighted material. Under copyright law, no parts of this document may be reproduced without the expressed permission of the author. An Abstract of An oral dosage form of ceftriaxone sodium using enteric coated sustained release calcium alginate beads by Darshan Lalwani Submitted to the Graduate Faculty as partial fulfillment of the requirements for the Master of Science Degree in Pharmaceutical Sciences with Industrial Pharmacy option The University of Toledo May 2015 Purpose: Ceftriaxone (CTZ) is a broad spectrum semisynthetic, third generation cephalosporin antibiotic. It is an acid labile drug belonging to class III of biopharmaceutical classification system (BCS). It can be solvated quickly but suffers from the drawback of poor oral bioavailability owing to its limited permeability through
    [Show full text]
  • TOWERS NURSING HOME, 2 West 106Th Street
    .. - Landmarks Preservation Colmlission August 17, 1976, Number I LP-0938 TOWERS NURSING HOME, 2 West 106th Street. 32 West 106th Street and 455 Central Park West. Borough of Manhattan. Original building, 1884-86; additions. 1889-90. and 1925-26; outbui !ding, 1886-87; architect Charles Coolidge Haight. Landmark Site: Borough of Manhattan Tax Map Block 1841, Lot 25. On July 13, 1976, the Landmarks Preservation Commission held a public · hearing on the proposed designation as a Landmark of the Towers Nursing Home and the proposed designation of the related Landmark Site (Item No. 9). The hearing had been duly advertised in accordance with the provisions of law. Twenty-one witnesses spoke in favor of designation. There were two speakers in opposition to designation. The Commission has also received many letters and other expressions of support in favor of designation. A number of letters have been received in opposition to designation. DESCRIPTION AND ANALYSIS The Towers Nursing Home, originally the New York Cancer Hospital, was built in three sections between 1884 and 1890 from plans by the noted New York City architect Charles Coolidge Haight. Prominently located at the wide · intersection of Centra·l Park West and West 106th Street, the Towers is a toea I point for the surrounding neighborhood, and with its towers crowned by conical roofs, is one of the most distinguished buildings facing Central Park. The New York Cancer Hospital was founded in 1884 to further the study and treatment of cancer. In 1882 John Jacob Astor had made an offer to the Woman's Hospital to fund a pavilion for the treatment of cancer patients.
    [Show full text]
  • 281165000 Dormitory Authority of the State Of
    NEW ISSUE Moody’s: “Aa2” Standard & Poor’s: “AA” FitchRatings: “AA” (See “Ratings” herein) $281,165,000 DORMITORY AUTHORITY OF THE STATE OF NEW YORK MEMORIAL SLOAN-KETTERING CANCER CENTER REVENUE BONDS, SERIES 2008A2 Dated: Date of Delivery Due: July 1, as shown on inside cover Payment and Security: The Memorial Sloan-Kettering Cancer Center Revenue Bonds, Series 2008A2 Bonds (the “Series 2008A2 Bonds”) are special obligations of the Dormitory Authority of the State of New York (the “Authority”) payable from and secured by a pledge of (i) certain payments to be made under the Loan Agreement (the “2002 Loan Agreement”), dated as of December 5, 2001, as amended, between Memorial Sloan-Kettering Cancer Center (the “Center”) and the Authority and Guaranties (the “Guaranties”), dated as of December 5, 2001, from the Sloan-Kettering Institute for Cancer Research and S.K.I. Realty, Inc. to the Authority (the “Revenues”) and (ii) all funds and accounts (excluding the Arbitrage Rebate Fund and any fund established for the payment of the Purchase Price of Option Bonds tendered for purchase) established under the Authority’s Memorial Sloan-Kettering Cancer Center Revenue Bond Resolution adopted December 5, 2001 and the Series 2008A Resolution adopted March 26, 2008 (collectively, the “Resolution”). The 2002 Loan Agreement is a general, unsecured obligation of the Center and requires the Center to pay, in addition to the fees and expenses of the Authority and the Trustee, amounts sufficient to pay the principal and Redemption Price of and interest on all Bonds issued under the Resolution, including the Series 2008A2 Bonds, as such payments become due.
    [Show full text]